Verition Fund Management
WVE icon

Verition Fund Management’s Wave Life Sciences WVE Stock Holding History

Verition Fund Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
40,000
-13,895
-26% -$92.1K ﹤0.01% 1810
2026
Q1 		$391K Buy
+53,895
New +$702K ﹤0.01% 1679
2025
Q3 		– Sell
-52,728
Closed -$343K – 4025
2025
Q2 		$343K Sell
52,728
-102,029
-66% -$674K ﹤0.01% 3136
2025
Q1 		$1.25M Buy
154,757
+72,874
+89% +$797K 0.01% 1948
2024
Q4 		$1.01M Buy
+81,883
New +$1.09M ﹤0.01% 2043
2024
Q3 		– Sell
-25,917
Closed -$129K – 3536
2024
Q2 		$129K Sell
25,917
-7,040
-21% -$40.2K ﹤0.01% 2692
2024
Q1 		$203K Buy
+32,957
New +$165K ﹤0.01% 2492
2023
Q4 		– Sell
-19,657
Closed -$113K – 2720
2023
Q3 		$113K Buy
+19,657
New +$89.7K ﹤0.01% 2102
2023
Q2 		– Sell
-54,841
Closed -$237K – 2593
2023
Q1 		$237K Buy
+54,841
New +$251K ﹤0.01% 1667

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Verition Fund Management's WVE Position: Q2 2026 in Review

Verition Fund Management reduced its Wave Life Sciences (WVE) stake by 26% in Q2 2026, selling an estimated $92.1K and leaving 40,000 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

Verition Fund Management first reported a position in WVE in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.25M in Q1 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Verition Fund Management held 40,000 shares of Wave Life Sciences worth $232K as of Q2 2026.
  • Verition Fund Management sold 13,895 Wave Life Sciences shares in Q2 2026, an estimated $92.1K.
  • Wave Life Sciences made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1810 holding.
  • Verition Fund Management first reported a position in Wave Life Sciences in Q1 2023 and has held it in 9 quarters since.
  • Verition Fund Management's Wave Life Sciences position peaked at $1.25M in Q1 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.